Contribution to an article defining the benefits of lentiviruses in BioPharm International
In a recent article in BioPharm International, Chris Spivey speaks about different types of viral vectors that are regularly used in gene therapy, each with its advantages and drawbacks.
Naiara Tejados from VIVEbiotech points out that the use of lentiviral vectors is safe and effective, and introduces some of the projects that VIVEbiotech is working on, always in lentiviruses. You can read the full article here: https://www.biopharminternational.com/view/balancing-aavs-versus-llvs